Literature DB >> 26090388

Transfection of Platyhelminthes.

Bárbara Moguel1, Raúl J Bobes1, Julio C Carrero1, Juan P Laclette1.   

Abstract

Flatworms are one of the most diverse groups within Lophotrochozoa with more than 20,000 known species, distributed worldwide in different ecosystems, from the free-living organisms in the seas and lakes to highly specialized parasites living in a variety of hosts, including humans. Several infections caused by flatworms are considered major neglected diseases affecting countries in the Americas, Asia, and Africa. For several decades, a particular interest on free-living flatworms was due to their ability to regenerate considerable portions of the body, implying the presence of germ cells that could be important for medicine. The relevance of reverse genetics for this group is clear; understanding the phenotypic characteristics of specific genes will shed light on developmental traits of free-living and parasite worms. The genetic manipulation of flatworms will allow learning more about the mechanisms for tissue regeneration, designing new and more effective anthelmintic drugs, and explaining the host-parasite molecular crosstalk so far partially inaccessible for experimentation. In this review, availability of transfection techniques is analyzed across flatworms, from the initial transient achievements to the stable manipulations now developed for free-living and parasite species.

Entities:  

Mesh:

Year:  2015        PMID: 26090388      PMCID: PMC4450235          DOI: 10.1155/2015/206161

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


1. Platyhelminth Transfection Studies

The phylum Platyhelminthes or flatworms represent one of the most diverse groups within Lophotrochozoa with about 20,000 species distributed worldwide including free-living and parasitic organism classified into 17 major groups [1, 2]. All these acoelomate worms have bilateral symmetry; they are hermaphrodite with some exceptions and have a simple centralized nervous system and a mesodermal germ layer [3, 4]. Flatworms are characterized by a high degree of morphological diversity and reproduction modes (Table 1). The phenomenon of asexual reproduction that is uncommon in the animal kingdom occurs in all major groups of flatworms. This supports the presence of a population of totipotent stem cells called “neoblasts” in free-living worms and “germ or germinal cells” on flukes and tapeworms [4]. Several human infections caused by flatworms are considered major neglected tropical diseases (NTDs) by the World Health Organization: cysticercosis, schistosomiasis, fascioliasis, paragonimiasis, and echinococcosis [5].
Table 1

Main characteristics of the groups where genetic transfection has been achieved*.

GroupBiologic interactionsAdult bodyLife cycleExample of genus
Tricladida Mostly free-livingNonsegmentedSimple Dugesia, Schmidtea
Trematoda Endoparasites of invertebrates and vertebratesNonsegmentedComplex Fasciola, Schistosoma
Cestoda Endoparasites of vertebratesSegmentedComplex Taenia, Echinococcus
Developing techniques to manipulate flatworms is a growing topic in contemporary research as judged by the number of reports published during the last decade [6]. Maintenance of parasite species under laboratory conditions has been challenging and genetic manipulation is still difficult [7]. However, since the 90s, attempts have been made to identify and characterize the regions controlling the expression of genes in several species of flatworms [8]. Due to the lack of a good expression system for heterologous genes in these organisms, several mammalian cell lines have been employed as transfection targets to identify functional promoters in flatworms [9, 10]. In this regard, the recently described genomes for several of these organisms, including the free-living planarian Schmidtea Mediterranean [11], and the parasites Schistosoma mansoni, S. japonicum [12, 13], Taenia solium [14, 15], Echinococcus granulosus, and E. multilocularis [15] represent a considerable advantage. Those genome projects allowed us to identify orthologous genes of each species and group and their functional promoters as well as to carry out in silico metagenomic studies. Transfection studies for each of the three groups of Platyhelminthes done so far are described in this short review.

1.1. Tricladida

Planarians have the capacity of regenerating complete worms from a small fragment of their bodies [16]. In 1981, Baguñà described a group of cells conferring these regenerative properties as “neoblasts” [16-18]. In order to understand the basis of tissue regeneration in these flatworms, several studies were conducted [18], which could represent a valuable contribution to human regenerative medicine [16] as well as to the establishment of stable germ cell lines useful in transfection studies [19]. However, it was not until the advent of the molecular biology and genetic tools that further investigation in this phenomenon was possible. Thus, in 1999 the Dglvs gene (Dugesia VASA-like) was reported as the first gene expressed in neoblasts [20] and, almost simultaneously, a successful application of RNA interference (RNAi) was reported [21]. Since then, several related neoblast genes have been described and strategies for transient transfections have been developed for Tricladida [16]. The most used method for introducing exogenous genes in the different stages of these organisms is microinjection, which is also frequently used for silencing genes such as Djpum, nanos, ß-catenin, ndk, DjFGFR1, and DjFGFR2 [16, 18, 22, 23]. This method, although highly efficient in adult flatworms, was very invasive for early developmental stages. More recently, a novel method for introducing exogenous materials into developing planarian embryos by nanosecond exposure of eggs to pulsed laser has been reported. This represents the first report of planarian embryos being genetically modified without compromising their normal development [17]. However, availability of suitable vectors for stable transfections is required to allow incorporation of exogenous genetic material into the genome of these organisms. For example, in the case of planarians three mobile elements (mariner, Hermes, and PiggyBac) have been introduced using the green fluorescent protein (EGFP: enhanced green fluorescent protein) as reporter gene, using microinjection followed by electroporation to transfect the parenchymal cells of adult flatworms [19]. Until now, the three transposons have shown good efficiency of integration into the genome in neoblast cells. PiggyBac and Hermes appear to be quite stable showing a good expression after eight months of transfection [19].

2. Digenean Trematodes

Trematode infections reach high prevalence in developing countries [5, 24]. The helminth infection with the largest global prevalence is schistosomiasis with 207 million cases worldwide, mainly caused by three species of blood flukes: S. haematobium, S. mansoni, and S. japonicum. In the case of trematodes, extensive studies on vaccines, drug development, and diagnostic methods are available [24]. Moreover, the complete genomes of S. mansoni and S. japonicum have been elucidated [12, 13]. Attempts of identifying genes and introducing heterologous genetic material have been carried out for more than a decade. New technologies have enabled success to identify, to silence, and to carry out transient transfections of several genes. Stable transfections have been achieved, allowing the approach to questions about the involvement of specific genes in disease pathogenesis or the identification of new target candidates for drug treatment [24]. Several reviews are available where the genomic history of schistosomes, including advances on transfection, is well organized [8, 10, 25–29]. Table 2 summarizes the progress in the transfection of S. mansoni and S. japonicum.
Table 2

Transfection of heterologous genes in Schistosomes.

SpeciesAgent and methodPromoter ReportergeneLife stage transfectedTransfection typeReferences
S. mansoni RNA and plasmid by particle bombardmentSpliced LeaderLuciferaseAdult wormTransient[34]
Plasmid by particle bombardment Hsp70GFPAdult worm and sporocystsTransient[35]
Plasmid by particle bombardmentER60GFPFemale miracidia with sporocystsTransient[36]
Plasmid by particle bombardmentSmCNAGFPAdult wormTransient[37]
Plasmid by particle bombardmentER60GFPAdult wormTransient[38]
Plasmid by particle bombardmentHsp70EGFPMiracidiaTransient[39]
RNA by electroporationLuciferaseSchistosomulaTransient[40]
RNA by particle bombardment and electroporationLuciferaseSporocysts, miracidia, and adult wormTransient[41]
VSVG-pseudo MMLV plasmid by cation polybreneSL and hsp70EGFP and LuciferaseSchistosomulaTransient[42]
ElectroporationSmACT1.1LuciferaseSchistosomula Transient[43]
PiggyBac by electroporationActin and HSP70LuciferaseSchistosomulaStable[44]
VSVG-pseudo MMLV plasmid by lipofectamineSma-ZincLuciferaseAdult worm and schistosomulaStable[45]
RNA and VSVG-pseudo MMLV by electroporationCY3 and luciferaseEggsStable[46]
MLV pseudotyped plasmid by lipofectamine or polyethylenimine MLV 5′, Pol II, vasa-like, Actin, Pol III U6Luciferase and EGFPSchistosomula, eggs, and adult wormsStable [47]

S. japonicum Plasmid by electroporationCMVEGFP and luciferaseSchistosomula and adult wormTransient[48]
VSVG-pseudo pantropic retrovirus plasmid by cation polybreneLTRhTERTSchistosomulaStable [49]

SL: splice leader, hsp70: heat-shock protein 70, ER60: endoplasmic reticulum 60, SmCNA: Schistosoma mansoni calcineurin 1, CMV: cytomegalovirus, SmAct 1: Schistosoma mansoni actin 1, Sma-Zinc: Schistosoma mansoni Zinc finger protein, hTERT: human telomerase reverse transcriptase, VSVG: vesicular stomatitis virus glycoprotein, MMLV: Moloney murine leukemia retroviral, and LTR: retrovirus long terminal repeat.

Other trematodes causing infections of high global prevalence (>40 million cases) [24], such as Clonorchis sinensis (liver fluke), Opisthorchis viverrini (liver fluke), Paragonimus spp (lung fluke), Fasciolopsis buski (intestinal fluke), and Fasciola hepatica (intestinal fluke), have not been successfully transfected; successful methodologies developed for S. mansoni could be adapted for these trematodes [27]. However, the promoter region of cathepsin 1 from F. hepatica has been characterized through transient transfection of mammalian Vero cells [30]. Another case is the Paragonimus westermani retrotransposon sequences belonging to three LTR (long terminal retrotransposons) retrotransposon families [31]. Two of these retrotransposon sequences appeared to maintain their mobile activities as suggested by the presence of mRNA transcripts [31]. The ability to integrate into the flatworm genome makes transposons and retrotransposons excellent candidates to develop stable transfections [32]. Three methods have been exploited for nucleic acid delivery into schistosomes [28]: biolistic (particle bombardment/gene gun), electroporation, and infectious retroviral vectors (Table 2). Electroporation has been considered as the most efficient method for transfection of sporocysts and schistosomules. However, biolistic has also been successfully used on miracidia and adults [33]. The choice of a delivery method depends on the organism and the life cycle stage under study. Moreover, experiences in schistosomes can also help to choose and adapt one transfection method on related organisms. An application of transient transfection methodologies is the silencing of specific genes through RNAi, involving studies on worm viability, development, tegument physiology, egg development, signaling pathways, and drug discovery. Efficacy of RNAi can be influenced by the method of delivery: the more often used in schistosomes are soaking and electroporation [8] and the most frequently used RNAi in schistosomes is dsRNA (long double stranded), followed by siRNA (small interfering) [29]. The properties of each RNAi have been important to define their use; for example, it has been suggested that siRNA accumulates faster in certain tissues [50], whereas dsRNA is more stable to RNAse digestion [51]. In addition, dsRNA experiments are cheaper than the siRNAs counterpart [29, 51]; however, siRNAs can be more efficient inhibitors when multiple sequence oligonucleotides are used against the same target [8, 28, 29, 51, 52]. Developments of RNA silencing in schistosomes and other trematodes have accumulated during the last decade (Table 3).
Table 3

RNA silencing in trematode parasites.

SpeciesRnaiTarget geneLife stage targetSilencing efficacyReferences
S. mansoni dsRNASGTP1 and GAPDHMiracidia and sporocyst70–80% (t); 40% (p)[55]
dsRNA SmCB1Schistosomula10-fold (t)[56]
dsRNA SmCB1 and SmCB31Cercariae and adult worms80% (t)[57]
dsRNA and siRNA SmAPCercariae and adult worms>90% (t); >70% (p)[58]
siRNASmRPNII/POH1Schistosomula80% (t)[59]
dsRNACathepsin DSchistosomula100% (t)[60]
siRNAHGPRTaseCercariae↓ 27% parasite load, 65% (t)[53]
dsRNASmLAP 1 and SmLAP2Eggs↓ 80% hatching[61]
dsRNA32 genes (antioxidants, transcription factors, cellular signaling, and metabolic enzymes)MiracidiaMobility, growth, and viability affected[62]
siRNA SmAPAdult worms80% (t)[63]
dsRNASmTK4Adult worms17–63% (p)[64]
dsRNA SmAQPAdult worms90–95% (t)[65]
dsRNASmPALAdult wormsInconsistent results[66]
dsRNASmGTP-1 and SmGTP-4Adult worms In vivo: SmGTP-1 55% (t), SmGTP-4 85% (t); In vitro: SmGTP-1, 70% (t), SmGTP-4, 90% (t)[67]
dsRNA11 genesSchistosomula40–75% (t)[68]
dsRNASmCa1 and SmCa2Miracidia35% (p)[69]
sh-RNALuciferaseSchistosomula47.5% (p)[70]
dsRNASmAPAdult worms95% (t)[71]
dsRNASm-NPP-1Schistosomula and adult worms55% (t) [72]
siRNASmCD59Schistosomula60% (t)[73]
dsRNASmCaMK2, SmJNK, SmERK1, SmERK2, and SmRasSchistosomulaSmERK1 92% (t), SmERK2 56% (t), SmRas 42% (t)[74]
dsRNASmACC-1 and SmACC-2SchistosomulaSmACC-1 60% (t), SmACC-2 90% (t) [75]
siRNASmAP, SmNPP-5, and SmATPDase1Schistosomula and Adult wormsSmAP 90% (t), SmNPP-5 >90% (t), SmATPDase1 80% (t) [54]
siRNASm5HTRSchistosomula and adult wormsLarvae: 100% (t) and ↓ 80% motility; adult male and female: 90% (t) and ↓ 60% motility, 80% (t) and ↓ 50% motility, respectively[76]

S. japonicum dsRNASjGCPAdult worms 75% (t)[77]
siRNA Mago NashiSchistosomula 66–81% (t) [78]
dsRNA Prxs 1 and Prxs 2Schistosomula and adult worms~20% (t)[79]
dsRNA(SHSP) Sjp40Adult worms80% (t)[80]
siRNASjAR (SiRNA1 and SiRNA2)Schistosomula48% (t) and 73% (t)[81]

S. haematobium siRNA and dsRNALuciferase and Sh-tsp-2Eggs, schistosomula, and adult worms >75% (p) for both[82]

F. hepatica dsRNAFheCL and FheCBMetacercariaeFheCL1: 80% (t) [83]
dsRNA FhLAPYoung larvae >90% (p)[84]

SGTP: facilitated diffusion glucose transporter, GAPDH: glyceraldehyde-3-phosphato-dehydrogenase, SmCB: Schistosoma mansoni cathepsin B, SmAP: Schistosoma mansoni alkaline phosphatase, SmRPNII/POH1: Schistosoma mansoni proteasome subunit, HGPRTase: hypoxanthine-guanine phosphoribosyl transferase, SmLAP: Schistosoma mansoni leucine aminopeptidase, SmTK4: Schistosoma mansoni SYK kinase, SmAQP: Schistosoma mansoni aquaporin gene, SmPAL: Schistosoma mansoni peptidylglycine alpha-amidating lyase, SmGTP: Schistosoma mansoni glucose transporter, SmCa: Schistosoma mansoni calmodulin sensing, Sm-NPP-1: Schistosoma mansoni neuropeptide precursor 1, SmCaMK: Schistosoma mansoni calmodulin-binding kinase, SmJNK: Schistosoma mansoni C-JUN-N-terminal kinase, SmERK: Schistosoma mansoni extracellular signal-regulated kinase, SmRAS: small GTPase superfamily, SmACC: Schistosoma mansoni acetylcholine-gated chloride channels, SmHTR: Schistosoma mansoni serotonin-activated G protein-coupled R, SjGCP: Schistosoma japonicum gynecophoral canal, Prxs: peroxiredoxin, Sjp40: Schistosoma japonicum short heat-shock protein, SjAR: Schistosoma japonicum aldose reductase, FheCL and FheCB: Fasciola hepatica cathepsin L and B, FhLAP: Fasciola hepatica leucine aminopeptidase, and sh-tsp-2: transcription of tetraspanin 2. (↓): knockdown; (t): transcript; (p): protein.

Table 3 shows that although the most widely used RNAi is dsRNA gene silencing also can be efficiently achieved with siRNA [29]. The RNAi agent and the delivery method can be defined after the gene target and the stage of the parasites are selected. It is worth mentioning that initial attempts towards knocking down the expression of S. mansoni essential genes through in vivo administration of siRNA on infected hosts have produced encouraging results [53]. This strategy, that takes advantage of the low mRNA levels of the homologue gene in the host's tissues (hypoxanthine-guanine phosphoribosyl transferase: HGPRTase), is restricted in the case of other essential genes [54].

3. Cestodes

Among cestodes the most important infections in public health are cysticercosis and hydatosis or echinococcosis, with high global prevalence in endemic countries [5, 85]. In the case of these parasites, extensive studies on immunodiagnosis, drug and vaccine development, and so forth have been carried out [85-87]. However, transfection studies on cestodes have been scarce. An important development in the manipulation of these parasites is the isolation of germinal cells lines. For T. crassiceps it was possible to regenerate complete cysticerci from cellular clusters [88]; for E. multilocularis new metacestodes were regenerated from the germinal layer [89]; in the case of E. granulosus, the isolation and in vitro maintenance and propagation of germinal cells have been reported [90, 91]. The most significant development in the transfection of cestode parasites was achieved on E. multilocularis using axenic cultures of metacestodes. After some time in coculture with rat hepatocytes, the germinal cells formed a laminar layer and then clustered until the regeneration of the metacestode vesicles [92]. The first attempts of a transient transfection were done by lipofection of germinal cells with a cyanofluorescent gene as a reporter under the control of elp (encoding the ezrin-radixin-moesin- (ERM-) like protein), an E. multilocularis gene promoter [92]. Transient expression of the fluorescent protein was detected. Furthermore, these cells of E. multilocularis were infected with the intracellular bacterium Listeria monocytogenes, demonstrating a good nucleic acid carrier system [92]. The use of an attenuated, self-destructive bacteria is exciting, as it can reach the cytosol of the host cells and induce the expression of a heterologous gene under the control of the P acta promoter [93]. This approach could be useful for other Platyhelminthes where cell lines can be isolated and maintained in vitro. In the case of gene silencing, an experiment in which elp and 14-3-3 were used as target genes, employing soaking and electroporation to deliver the siRNA, showed that the protein expression of 14-3-3 and elp decreases ~22% and ~72%, respectively, on day fifteen, after transfection of the protoscoleces of E. multilocularis [94]. Another silencing experiment was performed in the cestode of ruminants Moniezia expansa; the aim was to silence the transcription of actin (Me-act-1) gene using dsRNA. The reduction of actin expression was detected by immunohistochemistry and western blot techniques, in addition to severe damage in the morphology of tegument [95]. These studies demonstrated that the transfection and gene silencing techniques can be successfully used in cestodes. In fact, we have achieved successful transient transfection of T. crassiceps cysticerci in vitro by microinjection using a cytomegalovirus promoter and GFP as a reporter (submitted for publication). In addition, we are conducting assays to achieve stable transfection using PiggyBac transposon, as well as developing strategies for the introduction of dsRNA to silence target genes in T. crassiceps. Thus, the genetic manipulation of cestode parasites is currently under examination with the goal of developing reliable methodologies for stable transfection and in vitro maintenance of cell lines.

4. Conclusion

The new technologies for genetic manipulation and transgenesis have been used in trematode parasites, specifically in S. mansoni [29], which is a starting point for other flatworms. However, the progress in helminths and especially in cestodes has been limited by the inability to produce stable cell lines, although the recent advances in Echinococcus are encouraging. It is important to remark that the advance in Platyhelminth parasites is still limited in comparison with the protozoan parasitic organisms, where highly reproducible transfection methods, including stable transfections [9], have been available for some time. Transposons, bacteria, viruses, and constructs with sequences that allow integration of exogenous sequences into the flatworms genome have been already used, but successful experiments have been only reported for Schistosoma [10, 28, 29]. It is expected that similar gains can be achieved in other flatworms. If so, molecular helminthology will be transformed from descriptive to more functional investigations. The need to develop methods for the production and in vitro cultivation of germ cell lines for genetic manipulation is emphasized [89].
  93 in total

Review 1.  Manipulating the manipulators: advances in parasitic helminth transgenesis and RNAi.

Authors:  Bernd H Kalinna; Paul J Brindley
Journal:  Trends Parasitol       Date:  2007-03-23

2.  A PAL for Schistosoma mansoni PHM.

Authors:  Louise E Atkinson; Paul McVeigh; Michael J Kimber; Nikki J Marks; Betty A Eipper; Richard E Mains; Tim A Day; Aaron G Maule
Journal:  Mol Biochem Parasitol       Date:  2010-05-19       Impact factor: 1.759

3.  Transport of dsRNA into cells by the transmembrane protein SID-1.

Authors:  Evan H Feinberg; Craig P Hunter
Journal:  Science       Date:  2003-09-12       Impact factor: 47.728

4.  The Syk kinase SmTK4 of Schistosoma mansoni is involved in the regulation of spermatogenesis and oogenesis.

Authors:  Svenja Beckmann; Christin Buro; Colette Dissous; Jörg Hirzmann; Christoph G Grevelding
Journal:  PLoS Pathog       Date:  2010-02-12       Impact factor: 6.823

5.  RNA interference in Schistosoma mansoni schistosomula: selectivity, sensitivity and operation for larger-scale screening.

Authors:  Saša Stefanić; Jan Dvořák; Martin Horn; Simon Braschi; Daniel Sojka; Debbie S Ruelas; Brian Suzuki; Kee-Chong Lim; Stephanie D Hopkins; James H McKerrow; Conor R Caffrey
Journal:  PLoS Negl Trop Dis       Date:  2010-10-19

6.  The 26S proteasome in Schistosoma mansoni: bioinformatics analysis, developmental expression, and RNA interference (RNAi) studies.

Authors:  Joseph F Nabhan; Fouad El-Shehabi; Nicholas Patocka; Paula Ribeiro
Journal:  Exp Parasitol       Date:  2007-08-16       Impact factor: 2.011

7.  RNA interference of Schistosoma mansoni cathepsin D, the apical enzyme of the hemoglobin proteolysis cascade.

Authors:  Maria E Morales; Gabriel Rinaldi; Geoffrey N Gobert; Kristine J Kines; Jose F Tort; Paul J Brindley
Journal:  Mol Biochem Parasitol       Date:  2007-11-01       Impact factor: 1.759

8.  Divergent long-terminal-repeat retrotransposon families in the genome of Paragonimus westermani.

Authors:  Young-An Bae; Yoon Kong
Journal:  Korean J Parasitol       Date:  2003-12       Impact factor: 1.341

9.  On the three-finger protein domain fold and CD59-like proteins in Schistosoma mansoni.

Authors:  Leonardo P Farias; Greice Krautz-Peterson; Cibele A Tararam; Bogar O Araujo-Montoya; Tatiana R Fraga; Henrique K Rofatto; Floriano P Silva; Lourdes Isaac; Akram A Da'dara; R Alan Wilson; Charles B Shoemaker; Luciana C C Leite
Journal:  PLoS Negl Trop Dis       Date:  2013-10-24

10.  SmedGD: the Schmidtea mediterranea genome database.

Authors:  Sofia M C Robb; Eric Ross; Alejandro Sánchez Alvarado
Journal:  Nucleic Acids Res       Date:  2007-09-18       Impact factor: 16.971

View more
  3 in total

Review 1.  Transgenesis in parasitic helminths: a brief history and prospects for the future.

Authors:  M J Quinzo; M J Perteguer; P J Brindley; A Loukas; J Sotillo
Journal:  Parasit Vectors       Date:  2022-03-28       Impact factor: 3.876

2.  Lost and Found: Piwi and Argonaute Pathways in Flatworms.

Authors:  Santiago Fontenla; Gabriel Rinaldi; Jose F Tort
Journal:  Front Cell Infect Microbiol       Date:  2021-05-27       Impact factor: 5.293

3.  Conservation and diversification of small RNA pathways within flatworms.

Authors:  Santiago Fontenla; Gabriel Rinaldi; Pablo Smircich; Jose F Tort
Journal:  BMC Evol Biol       Date:  2017-09-11       Impact factor: 3.260

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.